Trial intelligence / Profile preview

Efficacy of mannitol on success rate of anesthesia in mandibular posterior teeth

IRCT20180228038901N1Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Jan 2017
Modality
Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 3 trial of Bronchitol in irreversible pulpitis, sponsored by Tabriz University of Medical Sciences. Primary endpoint: Success rate of anesthesia in mandibular posterior teeth. Started Jan 2017; status: completed.

02

Drugs

Bronchitol
03

Conditions

irreversible pulpitis

Beyond the preview

Go deeper on IRCT20180228038901N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180228038901N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call